BerriHealth Supports Cancer Research

BerriHealth continues to support research for the neuroendocrine tumor and carcinoid cancer community.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend

CCAN "Zebra" Ribbon

Funding for research in neuroendocrine tumors is extremely difficult to obtain through traditional funding sources.

Portland, Oregon (PRWEB) February 21, 2014

BerriHealth, a leader in providing high-quality black raspberry powder for clinical trials and directly to consumers online, has donated a portion of their 2013 sales to New Orleans Louisiana Neuroendocrine Tumor Specialists (NOLANETS), led by Dr. Eugene Woltering. The program is a collaborative effort between the Louisiana State University Health Sciences Center and the Ochsner Medical Center in Kenner Louisiana, and the money helps enable research for patients with neuroendocrine tumors (NETs). This is the third consecutive year that BerriHealth has made this donation.

Heading into 2014, BerriHealth is working to expand their support for cancer research. Customers can show support for neuroendocrine tumor research by using a promotion code, NETs, on their website, http://www.berrihealth.com. Any order placed with this code will have 5% of the purchase price donated to research focused on neuroendocrine tumors.

“Funding for research in neuroendocrine tumors is extremely difficult to obtain through traditional funding sources,” writes Dr. Woltering. Neuroendocrine tumors, and a specific type of NETs tumor, referred to as carcinoid tumors, have been commonly misdiagnosed in the past. With new research and increased medical awareness, there has been more focus on correctly diagnosing and treating NETs. More information on NETs can be found at http://www.carcinoidawareness.org.

“We believe in continuing to support this excellent work led by Dr. Woltering at NOLANETS. His team has done an excellent job advancing the understanding of NETs cancers, and we are proud to be a small part of that since 2011,” says Steve Dunfield, President of BerriHealth.

The black raspberry, grown mostly in Oregon, is prized for high levels of anthocyanins and polyphenols. Because of this special combination of phytonutrients in high concentrations, black raspberries have been studied in numerous clinical trials, and in NETs cancer research done by the NOLANETS team.

About BerriHealth

BerriHealth was founded in 2009 by Steve Dunfield when he teamed up with leading researcher Gary Stoner Phd, Emeritus Professor Ohio State University, and third generation farmer Don Sturm of Sturm’s Berry Farms. This unique combination of skills and knowledge was used to create a black raspberry powder that could be used by medical research universities across the United States to advance clinical research in a variety of fields.

BerriHealth has now made the same berry powders and extracts available directly to customers through their website, http://www.berrihealth.com, and has continued to innovate with new products using the black raspberry. Using their partnership with Sturm’s Berry Farm, the company has also started exploring the use of other quality berries to create signature powder blends.

For more information about BerriHealth, or supporting cancer research, please contact Steve Dunfield at (888) 761-8407.


Contact

Follow us on: Contact's Facebook Contact's Twitter